Cited by

• A therapeutic trial of pro-methylation dietary supplements in Angelman syndrome.

  Bird LM, Tan WH, Bacino CA, Peters SU, Skinner SA, Anselm I, Barbieri-Welge R, Bauer-Carlin A, Gentile JK, Glaze DG, Horowitz LT, Mohan KN, Nespeca MP, Sahoo T, Sarco D, Waisbren SE, Beaudet AL. Bird LM, et al. Am J Med Genet A. 2011 Dec;155A(12):2956-63. doi: 10.1002/ajmg.a.34297. Epub 2011 Oct 14. Am J Med Genet A. 2011. PMID: 22002941 Free PMC article. Clinical Trial.
• Synaptic plasticity in mouse models of autism spectrum disorders.

  Chung L, Bey AL, Jiang YH. Chung L, et al. Korean J Physiol Pharmacol. 2012 Dec;16(6):369-78. doi: 10.4196/kjpp.2012.16.6.369. Epub 2012 Dec 10. Korean J Physiol Pharmacol. 2012. PMID: 23269898 Free PMC article.
• Conserved characteristics of heterochromatin-forming DNA at the 15q11-q13 imprinting center.

  Greally JM, Gray TA, Gabriel JM, Song L, Zemel S, Nicholls RD. Greally JM, et al. Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14430-5. doi: 10.1073/pnas.96.25.14430. Proc Natl Acad Sci U S A. 1999. PMID: 10588722 Free PMC article.
• Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome.

  Tomaić V, Banks L. Tomaić V, et al. Cell Death Dis. 2015 Jan 29;6(1):e1625. doi: 10.1038/cddis.2014.572. Cell Death Dis. 2015. PMID: 25633294 Free PMC article.
• A clinical-translational review of sleep problems in neurodevelopmental disabilities.

  Peters SU, Shelton AR, Malow BA, Neul JL. Peters SU, et al. J Neurodev Disord. 2024 Jul 20;16(1):41. doi: 10.1186/s11689-024-09559-4. J Neurodev Disord. 2024. PMID: 39033100 Free PMC article. Review.